Page last updated: 2024-10-26

pentetic acid and Myasthenia Gravis

pentetic acid has been researched along with Myasthenia Gravis in 2 studies

Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.

Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Marienhagen, J1
Schalke, B1
Aebert, H1
Held, P1
Eilles, C1
Bogdahn, U1
Nordenbo, AM1
Somnier, FE1

Other Studies

2 other studies available for pentetic acid and Myasthenia Gravis

ArticleYear
Somatostatin receptor scintigraphy in thymoma imaging method and clinical application.
    Pathology, research and practice, 1999, Volume: 195, Issue:8

    Topics: Female; Humans; Male; Middle Aged; Myasthenia Gravis; Octreotide; Pentetic Acid; Radiopharmaceutical

1999
Acute deterioration of myasthenia gravis after intravenous administration of gadolinium-DTPA.
    Lancet (London, England), 1992, Nov-07, Volume: 340, Issue:8828

    Topics: Acute Disease; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Male; Middle Aged; Myasthenia Gr

1992